Protein kinases as drug targets:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Weinheim
Wiley-VCH
©2011
|
| Schriftenreihe: | Methods and principles in medicinal chemistry
49 |
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 Volltext |
| Beschreibung: | Includes bibliographical references and index With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed |
| Beschreibung: | 1 Online-Ressource (xxi, 373 pages) |
| ISBN: | 9783527633470 3527633472 9783527633487 3527633480 1283283247 9781283283243 9783527317905 3527317902 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043393179 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 9783527633470 |c electronic bk. |9 978-3-527-63347-0 | ||
| 020 | |a 3527633472 |c electronic bk. |9 3-527-63347-2 | ||
| 020 | |a 9783527633487 |c electronic bk. |9 978-3-527-63348-7 | ||
| 020 | |a 3527633480 |c electronic bk. |9 3-527-63348-0 | ||
| 020 | |a 1283283247 |9 1-283-28324-7 | ||
| 020 | |a 9781283283243 |9 978-1-283-28324-3 | ||
| 020 | |a 9783527317905 |9 978-3-527-31790-5 | ||
| 020 | |a 3527317902 |9 3-527-31790-2 | ||
| 024 | 7 | |a 10.1002/9783527633470 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn729724693 | ||
| 035 | |a (OCoLC)729724693 | ||
| 035 | |a (DE-599)BVBBV043393179 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615.798 |2 22 | |
| 245 | 1 | 0 | |a Protein kinases as drug targets |c edited by Bert Klebl, Gerhard Müller, and Michael Hamacher |
| 264 | 1 | |a Weinheim |b Wiley-VCH |c ©2011 | |
| 300 | |a 1 Online-Ressource (xxi, 373 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods and principles in medicinal chemistry |v 49 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed | ||
| 650 | 4 | |a Protein Kinase Inhibitors / therapeutic use | |
| 650 | 4 | |a Drug Delivery Systems | |
| 650 | 4 | |a Drug Discovery | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Protein kinases / Inhibitors | |
| 650 | 4 | |a Antineoplastic agents / Development | |
| 650 | 0 | 7 | |a Proteinkinasen |0 (DE-588)4175996-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Enzyminhibitor |0 (DE-588)4152479-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Proteinkinasen |0 (DE-588)4175996-5 |D s |
| 689 | 0 | 1 | |a Enzyminhibitor |0 (DE-588)4152479-2 |D s |
| 689 | 0 | 2 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Müller, Gerhard |e Sonstige |4 oth | |
| 700 | 1 | |a Klebl, Bert |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028811763 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175970427469824 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043393179 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn729724693 (OCoLC)729724693 (DE-599)BVBBV043393179 |
| dewey-full | 615.798 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.798 |
| dewey-search | 615.798 |
| dewey-sort | 3615.798 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03654nmm a2200685zcb4500</leader><controlfield tag="001">BV043393179</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527633470</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-3-527-63347-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527633472</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">3-527-63347-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527633487</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-3-527-63348-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527633480</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">3-527-63348-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283283247</subfield><subfield code="9">1-283-28324-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283283243</subfield><subfield code="9">978-1-283-28324-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527317905</subfield><subfield code="9">978-3-527-31790-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527317902</subfield><subfield code="9">3-527-31790-2</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9783527633470</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn729724693</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)729724693</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043393179</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.798</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protein kinases as drug targets</subfield><subfield code="c">edited by Bert Klebl, Gerhard Müller, and Michael Hamacher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim</subfield><subfield code="b">Wiley-VCH</subfield><subfield code="c">©2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xxi, 373 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods and principles in medicinal chemistry</subfield><subfield code="v">49</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Kinase Inhibitors / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein kinases / Inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents / Development</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Enzyminhibitor</subfield><subfield code="0">(DE-588)4152479-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Müller, Gerhard</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klebl, Bert</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028811763</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043393179 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:45Z |
| institution | BVB |
| isbn | 9783527633470 3527633472 9783527633487 3527633480 1283283247 9781283283243 9783527317905 3527317902 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028811763 |
| oclc_num | 729724693 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (xxi, 373 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Wiley-VCH |
| record_format | marc |
| series2 | Methods and principles in medicinal chemistry |
| spelling | Protein kinases as drug targets edited by Bert Klebl, Gerhard Müller, and Michael Hamacher Weinheim Wiley-VCH ©2011 1 Online-Ressource (xxi, 373 pages) txt rdacontent c rdamedia cr rdacarrier Methods and principles in medicinal chemistry 49 Includes bibliographical references and index With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed Protein Kinase Inhibitors / therapeutic use Drug Delivery Systems Drug Discovery MEDICAL / Pharmacology bisacsh Medizin Protein kinases / Inhibitors Antineoplastic agents / Development Proteinkinasen (DE-588)4175996-5 gnd rswk-swf Enzyminhibitor (DE-588)4152479-2 gnd rswk-swf Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Proteinkinasen (DE-588)4175996-5 s Enzyminhibitor (DE-588)4152479-2 s Arzneistoffträger (DE-588)4278196-6 s 2\p DE-604 Müller, Gerhard Sonstige oth Klebl, Bert Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Protein kinases as drug targets Protein Kinase Inhibitors / therapeutic use Drug Delivery Systems Drug Discovery MEDICAL / Pharmacology bisacsh Medizin Protein kinases / Inhibitors Antineoplastic agents / Development Proteinkinasen (DE-588)4175996-5 gnd Enzyminhibitor (DE-588)4152479-2 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
| subject_GND | (DE-588)4175996-5 (DE-588)4152479-2 (DE-588)4278196-6 (DE-588)4143413-4 |
| title | Protein kinases as drug targets |
| title_auth | Protein kinases as drug targets |
| title_exact_search | Protein kinases as drug targets |
| title_full | Protein kinases as drug targets edited by Bert Klebl, Gerhard Müller, and Michael Hamacher |
| title_fullStr | Protein kinases as drug targets edited by Bert Klebl, Gerhard Müller, and Michael Hamacher |
| title_full_unstemmed | Protein kinases as drug targets edited by Bert Klebl, Gerhard Müller, and Michael Hamacher |
| title_short | Protein kinases as drug targets |
| title_sort | protein kinases as drug targets |
| topic | Protein Kinase Inhibitors / therapeutic use Drug Delivery Systems Drug Discovery MEDICAL / Pharmacology bisacsh Medizin Protein kinases / Inhibitors Antineoplastic agents / Development Proteinkinasen (DE-588)4175996-5 gnd Enzyminhibitor (DE-588)4152479-2 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
| topic_facet | Protein Kinase Inhibitors / therapeutic use Drug Delivery Systems Drug Discovery MEDICAL / Pharmacology Medizin Protein kinases / Inhibitors Antineoplastic agents / Development Proteinkinasen Enzyminhibitor Arzneistoffträger Aufsatzsammlung |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9783527633470 |
| work_keys_str_mv | AT mullergerhard proteinkinasesasdrugtargets AT kleblbert proteinkinasesasdrugtargets |